Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Anne-Lotte van der Kooi

Postdoc
Reproductive health in childhood cancer survivors


Advances in cancer management have resulted in improved survival rates, particularly in children and young adults. However, treatment may adversely affect gonadal function and reproductive outcomes among survivors of childhood cancer. We examine various aspects of gonadal function and reproductive outcomes in survivors as compared to the general population. One large topic of research is part of a European wide endeavor (PanCareLIFE) and focuses on the identification of genetic factors which play a role in the risk of treatment-induced gonadal impairment among female childhood cancer survivors.
  • Effect of Genetic Variation in CYP450 on Gonadal Impairment in a European Cohort of Female Childhood Cancer Survivors, Based on a Candidate Gene Approach

    • sep. 2021
    • M E Madeleine, van der Perk, et al
    • Cancers
  • Health-related quality of life in Dutch adult survivors of childhood cancer

    • jul. 2021
    • L. M.E., van Erp, et al
    • European Journal of Cancer
  • TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study

    • jun. 2021
    • , et al
    • NPJ precision oncology
  • Possible modification of BRSK1 on the risk of alkylating chemotherapy-related reduced ovarian function

    • mrt. 2021
    • Anne-Lotte L F, van der Kooi, et al
    • Human reproduction (Oxford, England)
  • Usefulness of current candidate genetic markers to identify childhood cancer patients at risk for platinum-induced ototoxicity

    • okt. 2020
    • , et al
    • European Journal of Cancer
View all publications